NCT06164821View on ClinicalTrials.gov

Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2024

Study Completion Date

November 30, 2024

Conditions
Effect of Drug
Interventions
DRUG

luspatercept

Adult patients with TD thalassemia were given luspatercept subcutaneous injection.

Trial Locations (1)

650000

RECRUITING

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming

All Listed Sponsors
lead

Hematology department of the 920th hospital

OTHER